Affordable Access

Publisher Website

Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017-2018.

  • Ae, Ryusuke1
  • Makino, Nobuko2
  • Kosami, Koki2
  • Kuwabara, Masanari2
  • Matsubara, Yuri2
  • Nakamura, Yosikazu2
  • 1 Division of Public Health, Center for Community Medicine, Jichi Medical University, Tochigi, Japan. Electronic address: [email protected] , (Japan)
  • 2 Division of Public Health, Center for Community Medicine, Jichi Medical University, Tochigi, Japan. , (Japan)
Published Article
The Journal of pediatrics
Publication Date
Oct 01, 2020
DOI: 10.1016/j.jpeds.2020.05.034
PMID: 32454114


To report the epidemiologic characteristics, treatments, and cardiac complications of Kawasaki disease, using data from the nationwide survey in Japan. The nationwide Kawasaki disease survey in Japan has been conducted biennially since 1970. The most recent survey was completed in 2019, obtaining information for patients who developed Kawasaki disease during 2017-2018. Survey respondents were hospitals specializing in pediatrics and those with ≥100 beds and a pediatric department throughout Japan, where patients with Kawasaki disease were eventually hospitalized. The survey identified 32 528 patients with Kawasaki disease, which consisted of 15 164 (46.6%) in 2017 and 17 364 (53.4%) in 2018. The highest annual incidence rate was recorded in 2018 (359 per 100 000 children aged 0-4 years). After 1982, patients with ≤4 principal Kawasaki disease signs gradually increased, resulting in 6847 (21.1%) patients diagnosed during 2017-2018. Among the 30 784 patients receiving initial intravenous immunoglobulin administration, 6061 (19.7%) did not respond. Within 30 days of Kawasaki disease onset, 9.0% of patients were diagnosed with cardiac complications, and 2.6% of patients developed cardiac sequelae after the acute illness. The annual number of patients developing Kawasaki disease in Japan increased from 1970 through 2018, whereas the proportion of patients with Kawasaki disease with cardiac complications decreased in the most recent 2 decades. Early diagnosis of Kawasaki disease as well as advances in initial treatments could explain these findings. Copyright © 2020 Elsevier Inc. All rights reserved.

Report this publication


Seen <100 times